The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1560
ISSUE 1560
November 19, 2018
Issue 1560
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Vaccines for Travelers
November 19, 2018 (Issue: 1560)
Persons planning to travel outside the US should be
up to date on routine vaccines and, depending on their
destination, duration of travel, and planned activities,
may also receive certain travel-specific vaccines.
Tickborne encephalitis and...more
- Adult immunization. Med Lett Drugs Ther 2018; 60:73.
- DO Freedman et al. Medical considerations before international travel. N Engl J Med 2016; 375:247.
- AT Kroger et al. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Available at: https://www.cdc.gov. Accessed November 8, 2018.
- KK Wong et al. Recommendations of the Advisory Committee on Immunization Practices for use of cholera vaccine. MMWR Morb Mortal Wkly Rep 2017; 66:482.
- An oral cholera vaccine for travelers (Vaxchora). Med Lett Drugs Ther 2016; 58:113.
- WH Chen et al. Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae 01 El Tor. Clin Infect Dis 2016; 62:1329.
- KH Jacobsen. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med 2018; 8(10).
- A Rosdahl et al. An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression – a prospective, open-label, multi-center study. Travel Med Infect Dis 2018; 21:43.
- JJ Ott and ST Wiersma. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; 17:e939.
- Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) summary report, February 21-22, 2018, Atlanta, Georgia. Available at: www.cdc.gov. Accessed November 8, 2018.
- NP Nelson. Updated dosing instructions for immune globulin (human) GamaSTAN S/D for hepatitis A virus prophylaxis. MMWR Morb Mortal Wkly Rep 2017; 66:959.
- A Schweitzer et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386:1546.
- DF Johnson et al. Hepatitis B and C infection in international travelers. J Travel Med 2013; 20:194.
- A two-dose hepatitis B vaccine for adults (Heplisav-B). Med Lett Drugs Ther 2018; 60:17.
- S Schillie et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018; 67(1):1.
- M Goeijenbier et al. Travellers and influenza: risks and prevention. J Travel Med 2016; 24(1).
- Influenza vaccine for 2018-2019. Med Lett Drugs Ther 2018; 60:169.
- Centers for Disease Control and Prevention. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR Morb Mortal Wkly Rep 2009; 58:312.
- SL Hills et al. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010; 82:930.
- E Mirzaian et al. Mosquito-borne illnesses in travelers: a review of risk and prevention. Pharmacotherapy 2010; 30:1031.
- A new Japanese encephalitis vaccine (Ixiaro). Med Lett Drugs Ther 2009; 51:66.
- Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:898.
- T Jelinek et al. Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: a phase III multicenter, observer-blind study. J Travel Med 2015; 22:225.
- JP Cramer et al. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series. J Travel Med 2016; 23(3).
- M Paulke-Korinek et al. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis. Vaccine 2015; 33:3600.
- PA Gastañaduy et al. Measles - United States, January 1-May 23, 2014. MMWR Morbid Mortal Wkly Rep 2014; 63:496.
- HQ McLean et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-4):1.
- Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press, 2017. Available at: https://wwwnc.cdc.gov. Accessed November 8, 2018.
- A new conjugate meningococcal vaccine (Menveo). Med Lett Drugs Ther 2010; 52:59.
- JR MacNeil et al. Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013. MMWR Morb Mortal Wkly Rep 2014; 63:527.
- AC Cohn et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-2):1.
- M Kobayashi et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015; 64:944.
- GS Wallace et al. Interim CDC guidance for polio vaccination for travel to and from countries affected by wild poliovirus. MMWR Morb Mortal Wkly Rep 2014; 63:591.
- C Malerczyk et al. Imported human rabies cases in Europe, the United States, and Japan, 1990 to 2010. J Travel Med 2011; 18:402.
- AJ Nigg and PL Walker. Overview, prevention, and treatment of rabies. Pharmacotherapy 2009; 29:1182.
- CE Rupprecht et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2010; 59(RR-2):1.
- M Uwanyiligira et al. Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations. Clin Infect Dis 2012; 55:201.
- Prevention and treatment of pertussis. Med Lett Drugs Ther 2012; 54:73.
- M Tashani et al. Tetanus-diphtheria-pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (co-administered with quadrivalent meningococcal TT-conjugate vaccine): a randomized, controlled trial. J Travel Med 2017; 24(4).
- C Greenaway et al. Summary of the Statement on International Travellers and Typhoid by the Committee to Advise on Tropical Medicine and Travel (CATMAT). Can Commun Dis Rep 2014; 40:60.
- JA Whitaker et al. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 2009; 16:46.
- JE Staples et al. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-7):1.
- JE Staples et al. Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:647.
- RE Thomas et al. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria? Vaccine 2013; 31:6201.
- RE Thomas et al. The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am J Trop Med Hyg 2012; 86:359.
- MF Farez and J Correale. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol 2011; 68:1267.
- S Kuhn et al. Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk. CMAJ 2011; 183:E243.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1560
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
